Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



BIENAIME JEAN JACQUES Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 4,000 shares @ $88.1, valued at $352.4k
Sold 6,000 shares @ $88.29, valued at $529.7k
08/08/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 BIENAIME JEAN JACQUES (Director) has filed a Form 4 on INCYTE CORP
Txns: Granted 2,505 shares @ $0
Granted 11,294 options to buy @ $61.44, valued at $693.9k
05/16/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Paid exercise price by delivering 6,337 shares @ $93.93, valued at $595.2k
Paid exercise price by delivering 33,644 shares @ $93.93, valued at $3.2M
Exercised 39,130 options to buy @ $67.81, valued at $2.7M
Exercised 7,370 options to buy @ $67.81, valued at $499.8k
05/15/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 24,439 shares @ $94.55, valued at $2.3M
Sold 5,561 shares @ $95.22, valued at $529.5k
Exercised 30,000 options to buy @ $67.81, valued at $2M
05/11/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 317 shares @ $66.88, valued at $21.2k
Sold 13,626 shares @ $94.22, valued at $1.3M
Sold 14,964 shares @ $95.49, valued at $1.4M
Sold 1,410 shares @ $95.9, valued at $135.2k
Exercised 30,000 shares @ $67.81, valued at $2M
Sold 21,453 shares @ $94.65, valued at $2M
Sold 8,547 shares @ $95.34, valued at $814.9k
Exercised 30,000 options to buy @ $67.81, valued at $2M
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 144 Form 144 - Report of proposed sale of securities:
04/06/2023 144 Form 144 - Report of proposed sale of securities:
03/17/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 36,100 shares @ $0
Paid exercise price by delivering 9,437 shares @ $87.74, valued at $828k
Paid exercise price by delivering 88,623 shares @ $93.41, valued at $8.3M
Granted 49,430 options to buy @ $87.74, valued at $4.3M
03/14/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 15,000 shares @ $92.28, valued at $1.4M
Sold 8,000 shares @ $90.45, valued at $723.6k
Exercised 15,000 options to buy @ $67.81, valued at $1M
Exercised 8,000 options to buy @ $67.81, valued at $542.5k
03/13/2023 144 Form 144 - Report of proposed sale of securities:
03/10/2023 144 Form 144 - Report of proposed sale of securities:
03/02/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 89,700 shares @ $0
Granted 44,860 shares @ $0
Granted 32,972 shares @ $0
02/14/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Gifted 200 shares @ $0
Gifted 100 shares @ $0
Sold 15,000 shares @ $110.11, valued at $1.7M
Exercised 6,000 shares @ $67.81, valued at $406.9k
Sold 6,000 shares @ $109.15, valued at $654.9k
Exercised 15,000 options to buy @ $67.81, valued at $1M
Exercised 6,000 options to buy @ $67.81, valued at $406.9k
02/13/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/18/2023 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 10,000 shares @ $112.25, valued at $1.1M
Sold 10,000 shares @ $111.55, valued at $1.1M
Exercised 10,000 options to buy @ $67.81, valued at $678.1k
Exercised 10,000 options to buy @ $67.81, valued at $678.1k
12/15/2022 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 1,000 shares @ $106.89, valued at $106.9k
12/06/2022 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Small acquisition of 100 shares @ $86.1178, valued at $8.6k
Sold 471 shares @ $103.97, valued at $49k
Sold 600 shares @ $103.971, valued at $62.4k
Sold 260 shares @ $103.98, valued at $27k
Sold 100 shares @ $104, valued at $10.4k
Sold 69 shares @ $104.055, valued at $7.2k
10/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2022 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 20,000 shares @ $81.91, valued at $1.6M
Exercised 20,000 options to buy @ $37.46, valued at $749.2k
04/18/2022 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 10,000 shares @ $83.66, valued at $836.6k
Exercised 10,000 options to buy @ $37.46, valued at $374.6k
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2022 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 34,780 shares @ $0
01/14/2022 4 BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Small acquisition of 100 shares @ $89.2246, valued at $8.9k
Sold 5,000 shares @ $89, valued at $445k
Sold 5,000 shares @ $87.86, valued at $439.3k
Exercised 5,000 options to buy @ $37.46, valued at $187.3k
Exercised 5,000 options to buy @ $37.46, valued at $187.3k
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy